RESUMEN
OBJECTIVES: Infectious endophthalmitis has occurred despite the use of antibiotics in irrigating solutions during implantation of intraocular lenses (IOLs). This infection is generally resistant to antibiotic therapy and, therefore, removal of the implant is necessary before eradication of the infection. This study was designed to assess the role of chosen dispersants and anti-adhesives in inhibiting Staphylococcus epidermidis hydrophobicity, adhesion, slime production and subsequently biofilm formation on IOLs. METHODS: The relative activity of several potential slime dispersants and anti-adhesives on slime production, hydrophobicity and the adherence of S. epidermidis to IOLs and the degrees to which their effects enhance antibiotic activities were investigated. RESULTS AND CONCLUSIONS: The MBCs of antibiotics against S. epidermidis strains in a biofilm increased 10-16 times compared with those against bacterial strains in suspension. Addition of slime dispersants or anti-adhesives reversed the susceptibility of the strains in a biofilm to that of bacteria in suspension. Slime production by S. epidermidis strains was significantly diminished by dispersants. Anti-adhesives, hyaluronan, heparin and carpobol 934 exerted less effects on slime production than dispersants. Addition of slime dispersants or anti-adhesives to cell cultures resulted in a significant reduction in bacterial surface hydrophobicity compared with control untreated cultures (at P < 0.001). Reduction of slime production and bacterial surface hydrophobicity led to a marked decrease in the adherence of S. epidermidis to IOLs. Slime dispersants were more effective at reducing bacterial adherence than anti-adhesives. Simultaneous use of antibiotics with slime dispersants or anti-adhesives will exert a more beneficial effect during IOL implantation.
Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Lentes Intraoculares/microbiología , Staphylococcus epidermidis/efectos de los fármacos , Adhesión Bacteriana/efectos de los fármacos , Sinergismo Farmacológico , Heparina/farmacología , Humanos , Ácido Hialurónico/farmacología , Interacciones Hidrofóbicas e Hidrofílicas , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana , Polisacáridos Bacterianos/metabolismo , Staphylococcus epidermidis/químicaRESUMEN
Carboplatin (CP), a second generation platinum compound, is effective against various types of cancers, producing less nephrotoxicity and ototoxicity but more myelotoxicity than cisplatinum. CP-myelosuppression is the rate-limiting step of its clinical use. Prevention of CP-myelosuppression is a major target in the field of chemotherapy. Therefore, the present study investigates the use of L-carnitine (LCR)-an antioxidant, cardioprotective, neuroprotective, and immunostimulant nontoxic natural compound-to protect against CP-induced myelosuppression. The viability of BMC was studied using a trypan blue exclusion technique following incubation with CP and/or LCR as a function of time and concentration. Apoptosis was tested for by detecting the amount of DNA fragmentation and the visualization of DNA ladders upon gel electrophoresis. Bone marrow progenitor cell function was examined by colony forming unit assay. Cellular contents of glutathione (GSH) and malondialdehyde (MDA) were also estimated. Results revealed that LC50 of CP is 4.7 mM and the highest safe concentration of LCR is 5 mM. Co-exposure of LCR+CP rescued BMC viability by 37% compared to the CP-treated cultures. The LCR halts CP-induced apoptosis and it significantly improves the function of the bone marrow progenitors by increasing the number of colony-forming units as a response to granulocyte/macrophage colony stimulating factors. Finally, LCR restores CP-induced GSH depletion and prevents MDA elevation in BMC. In summary, the results suggest that LCR is able to protect against CP-induced myelosuppression, which suggests its use as an adjuvant therapy. This finding merits further investigation into the mechanism(s) of such protection as well as its interaction with CP antitumor activity.
Asunto(s)
Antineoplásicos/antagonistas & inhibidores , Antineoplásicos/toxicidad , Apoptosis/efectos de los fármacos , Células de la Médula Ósea/efectos de los fármacos , Carboplatino/antagonistas & inhibidores , Carboplatino/toxicidad , Carnitina/farmacología , Animales , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ensayo de Unidades Formadoras de Colonias , Glutatión/metabolismo , Granulocitos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Ratas , Ratas WistarRESUMEN
BACKGROUND: The emergence of infection caused by invasive penicillinnonsusceptible (PNS) and multidrug-resistant strains of Streptococcus pneumoniae has become a worldwide concern, necessitating the epidemiologic surveillance of such strains. OBJECTIVES: One aim of this study was to identify clones of invasive PNS S pneumoniae among isolates in Riyadh, Saudi Arabia. The second aim was to compare these clones with international clones to track their spread in Saudi Arabia. METHODS: The phenotypes of invasive isolates characterized as S pneumoniae were determined using susceptibility testing and serotyping (capsular test and E-test). The genotypes of PNS isolates were determined using random amplified polymorphic DNA analysis. The genetic relatedness of these local strains to the international widespread clones was investigated. RESULTS: Of 296 S pneumoniae isolates identified using biochemical and culture characteristics, 89 (30.1%) were invasive. Susceptibility testing using the E-test revealed that 17 of the 89 invasive isolates (19.1%) were PNS. Most of the 89 isolates (89.9%) were resistant to sulfamethoxazole-trimethoprim; 32.6% and 23.6% of isolates were resistant to chloramphenicol and tetracycline, respectively. All of the isolates (100.0%) were fully susceptible to ceftriaxone and vancomycin. Capsular serotyping of the 89 isolates showed that 19A (18.0%), 613 (14.6%), 23F (13.5%), 9V (11.2%), 14 (6.7%), 19F (5.6%), and 18C (4.5%) were the most predominant serogroups/serotypes. The 17 PNS strains were confirmed on polymerase chain reaction to have penicillin resistance genes. Of these 17 strains, international clone 19A-a was the most predominant (41.2%), followed by 6B-a (17.6%), and 23F-a and 9V-a (each, 11.8%). CONCLUSIONS: The present study identified the spread of the 4 most commonPNS S pneumoniae isolates (clones)-19A, 613, 23F, and 9V-to Riyadh, but identified no new clones among patients having invasive infection with S pneumoniae in Riyadh. This study emphasizes that international PNS clones have contributed to the prevalence and spread of PNS pneumococci among the clinical isolates in Saudi Arabia.
RESUMEN
Clinical isolates of Moraxella catarrhalis (76 isolates) were screened for beta-lactamase production and antibiotic susceptibility. beta-Lactamases (detected in 90.8% of isolates) were typed using isoelectric focusing to BRO-1 (87%) and BRO-2 (13%). Minor variations in electrofocusing patterns between the two types were seen. Isolates expressing BRO type enzymes showed solid resistance to penicillin, ampicillin and cephalothin, in particular BRO-1 producers. BRO-1 isolates were less susceptible to cephems and to beta-lactamase inhibitors than BRO-2 isolates. Isolates harbouring BRO-1 enzymes have more enzymatic activity than those expressed by BRO-2 isolates. Apart from resistance to tetracycline (14.5%), all isolates were consistently susceptible to erythromycin, chloramphenicol, ciprofloxacin and gentamicin. The conjugal transfer of BRO beta-lactamase gene(s) between M. catarrhalis isolates occurred with a frequency of 10(-5) to 10(-7)/donor cell. The data emphasize the importance of M. catarrhalis as an etiological agent spreading beta-lactamases that may inhibit some beta-lactams and lead to failure in treatment of mixed infections.